The AAT-AD/PD Focus Meeting 2020 will be a held as a virtual meeting. The meeting will, for a second year, present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
We invite you to attend the presentation from Sebastian Illes, Director of CNS research at Cellectricon, titled:
In vitro modeling of synucleinopathy on a high capacity microfluidics platform
Abstract Number: 521
Date: April 2
Available from: 8 AM
If you are interested in learning more about Cellectricon’s drug discovery services you are very welcome to reach out to us.
If you would like to learn more about Cellectricon’s drug discovery services for pain and neurodegenerative disease research, you are very welcome to reach out and schedule a meeting with us.